ConductScience.org, home

Paper39609558

Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses.

Rezaei R and 33 others. Nat Biomed Eng, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses. Papers, record 39609558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39609558

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses.
PubMed
Journal
Nat Biomed Eng
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.72, provisional
iCite
Revised in PubMed
2025-06-18
PubMed

Authors34

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rezaei RReza
2Boulton SStephen
3Ahmadi MMahsa
4Petryk JJulia
5Da Silva MMileshttps://orcid.org/0009-0006-4586-3629
6Kooshki Zamani NNika
7Singaravelu RRagunathhttps://orcid.org/0000-0002-2692-3650
8St-Laurent GGabriel
9Daniel LLauren
10Sadeghipour AArezoo
11Pelin AAdrian
12Poutou JJoanna
13Munoz Zuniga AIAbril Ixchel
14Choy CClarence
15Gilchrist VHVictoria H
16Khalid ZZumama
17Austin BBradley
18Onsu KAKemal Alper
19Marius RRicardo
20Ameli ZZahra

Source PubMed

See all 34 authorsDownload CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Oncolytic VirusesMajor topic
CytokinesMajor topic
Anti-Bacterial AgentsMajor topic
Humans
Transgenes
Herpesvirus 1, Human
Oncolytic Virotherapy
Vaccinia virus
Animals
Cell Line, Tumor
Virus Replication
Mutagenesis, Insertional
Mutagenesis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
448323Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (Skin Research Training Centre)PubMed

Source PubMed

Download CSV of grants

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117299401History of oncolytic viruses: genesis to genetic engineering.Mol Ther2007https://conductscience.org/library/papers/17299401PubMed
232071927Oncolytic Viruses and the Immune System: The Dynamic Duo.Mol Ther Methods Clin Dev2020https://conductscience.org/library/papers/32071927PubMed
338283361Oncolytic vaccinia virus and cancer immunotherapy.Front Immunol2023https://conductscience.org/library/papers/38283361PubMed
432297534Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity.Expert Opin Biol Ther2020https://conductscience.org/library/papers/32297534PubMed
529576283Armed oncolytic viruses: A kick-start for anti-tumor immunity.Cytokine Growth Factor Rev2018https://conductscience.org/library/papers/29576283PubMed
637041165Oncolytic virotherapy: basic principles, recent advances and future directions.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37041165PubMed
719169955Diplomatic immunity: turning a foe into an ally.Curr Opin Mol Ther2009https://conductscience.org/library/papers/19169955PubMed
82994215Genetic engineering of novel genomes of large DNA viruses.Science1985https://conductscience.org/library/papers/2994215PubMed
935584888The Life Cycle of the Vaccinia Virus Genome.Annu Rev Virol2022https://conductscience.org/library/papers/35584888PubMed
1026462293Designing Herpes Viruses as Oncolytics.Mol Ther Oncolytics2015https://conductscience.org/library/papers/26462293PubMed
117607536Selection of recombinant vaccinia viruses on the basis of plaque formation.Gene1995https://conductscience.org/library/papers/7607536PubMed
1233144673Rapid poxvirus engineering using CRISPR/Cas9 as a selection tool.Commun Biol2020https://conductscience.org/library/papers/33144673PubMed
1331617178CRISPR/Cas9-Based Genome Editing of HSV.Methods Mol Biol2020https://conductscience.org/library/papers/31617178PubMed
1436713447CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.Front Immunol2022https://conductscience.org/library/papers/36713447PubMed
1534200544Methods for the Manipulation of Herpesvirus Genome and the Application to Marek's Disease Virus Research.Microorganisms2021https://conductscience.org/library/papers/34200544PubMed
1611435572Effects of DNA structure and homology length on vaccinia virus recombination.J Virol2001https://conductscience.org/library/papers/11435572PubMed
1723209131Tinkering with translation: protein synthesis in virus-infected cells.Cold Spring Harb Perspect Biol2013https://conductscience.org/library/papers/23209131PubMed
1812209136Viruses and interferon: a fight for supremacy.Nat Rev Immunol2002https://conductscience.org/library/papers/12209136PubMed
1932455727Vaccinia Virus as a Master of Host Shutoff Induction: Targeting Processes of the Central Dogma and Beyond.Pathogens2020https://conductscience.org/library/papers/32455727PubMed
2034051235Choice of selectable marker affects recombinant protein expression in cells and exosomes.J Biol Chem2021https://conductscience.org/library/papers/34051235PubMed

See all 60 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42039816Oncolytic viruses in lung cancer: mechanisms of action and research progress.Front Microbiol2026https://conductscience.org/library/papers/42039816PubMed
41917920Bridging mechanism and clinic: unlocking the full potential of oncolytic virus-based immunotherapy.Mol Cancer2026https://conductscience.org/library/papers/41917920PubMed
41593888Application of artificial intelligence in head and neck squamous cell carcinoma.Ann Med2026https://conductscience.org/library/papers/41593888PubMed
41291902TIM-3 blockade reverses oncolytic vaccinia virus-induced DCs inactivation and T cells exhaustion to improve antitumor immunity and therapeutic efficacy.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/41291902PubMed
40723208Vaccinia Virus-A Swiss Army Knife Against Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/40723208PubMed
40143547Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation.Mol Ther2025https://conductscience.org/library/papers/40143547PubMed
39609557Antibiotic-driven boosting of oncolytic virotherapy.Nat Biomed Eng2025https://conductscience.org/library/papers/39609557PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39609558

GET https://conductscience.org/api/papers/v1/39609558/authors?page=2